Recently, it has become clear that the developmental Hedgehog pathway is activated in ischemic adult tissue where it aids in salvaging damaged tissue. The exact driving force for the initial Hedgehog response is unclear and as most physiological and cellular processes are disturbed in ischemic tissue, Hedgehog-activating signals are hard to dissect. Here, we demonstrate that hypoxia per se is able to induce a rapid systemic Hedgehog response in mice, as evident from expression of the pathway ligand, Sonic hedgehog, as well as the pathway activity marker Patched1 in various organs. Using in vitro models of hypoxia, we showed that the Hedgehog response was transient and preceded by the accumulation of HIF-1α which we hypothesized to communicate between hypoxia and Hedgehog expression. Indeed, pharmacological inhibition, knockdown or genetic ablation of HIF-1α abolished Hedgehog pathway activation. Concluding, we have established that hypoxia is translated into a Hedgehog response through HIF-1α and this mechanism is likely to be responsible for the Hedgehog response observed in various ischemia models.
Introduction
The Hedgehog (Hh) family of proteins (Bijlsma et al., 2004) is important in many patterning events in the developing embryo like for instance in determining digit position (Riddle et al., 1993) and the development of the nervous system (Echelard et al., 1993) . Hh signal transduction is highly unusual and some of its pathway components act in a rather unique manner (Bijlsma et al., 2004) . As shown in Fig. 1A , the Hh pathway has two receptors, i.e. the 12-pass transmembrane receptor Patched 1 (Ptch1) (Marigo et al., 1996) and the 7-pass transmembrane receptor Smoothened (Smo) (Alcedo et al., 1996) . When the pathway is active, due to binding of Sonic hedgehog (Shh) to Ptch1 (thereby alleviating its inhibitory action on Smo), target gene transcription is initiated through the Gli family of transcription factors (Murone et al., 1999) . One of these target genes is Ptch1, creating a negative feedback loop (Jeong and McMahon, 2005) , and increased expression of Ptch1 is thus indicative of pathway activity. Assaying Ptch1 levels thus enables to analyze tissue responses to generated Shh.
Recently, it has become clear that the Hh pathway is not only active in the developing embryo, but also in the adult organism. Intestinal tract morphostasis is critically dependent on proper Hh signaling (van den Brink et al., 2004) and Hh functions in a range of beneficial processes to salvage damaged tissue in different ischemia models (Kusano et al., 2004; Pola et al., 2003; Pola et al., 2001) . Recent work by Kusano et al. has shown the involvement of Hh in myocardial ischemia, and the use of Shh cDNA enabled the authors to reduce apoptosis in the afflicted area, to recruit progenitor cells, and to enhance tissue vascularization (Kusano et al., 2005) . The salvage experiments using Shh protein or -DNA in the abovementioned papers look like promising therapeutic options but although the authors provide an in-depth description of the involvement of Shh in their experiments, the exact mechanism driving Shh expression during ischemia remains unknown. In this study, we set out to examine whether hypoxia per se could induce Hh upregulation and to elucidate the mechanism behind this response.
The response to hypoxic conditions is usually mediated through the hypoxia inducible factors (HIFs, reviewed in (Schumacker, 2005) ). Under normal oxygen conditions, the HIF-1α transcription factor is constitutively synthesized, but also subject to degradation thereby keeping HIF-1α protein 
Results

Hypoxia induces a widespread Shh response in mice
To study the possible involvement of the Hh pathway in hypoxia, mice were subjected to decreasing concentrations of oxygen. In contrast to previous observations (Ertel et al., 1995; Knoferl et al., 2000; Lawson et al., 1997) , the threshold of non-lethal hypoxia was 8% O 2 in our hands. The previously reported level of 5 or 6% O 2 caused immediate death in our animals. At the observed threshold of 8% O 2 , the mice became severely hypoxic within one hour (arterial pO 2 decreased from 90 mm Hg to 35 mm Hg).
To evaluate the activation of the Hh pathway in hypoxic tissue, we performed Western blot analysis for Shh on whole organ homogenates from mice exposed to hypoxia for different time periods . Fig 1 B shows increased expression of Shh in spleen, liver, brain and to a lesser extent in lung following hypoxia. This is unexpected, as the expression of Shh in the adult organism is anticipated to be rather limited. However, the observed Shh response to hypoxia is reminiscent of the upregulation seen in ischemia experiments and might provide a mechanistic explanation for these previous findings.
Quantification of Western blot analysis for Ptch1 (Fig 1C) shows Ptch1 upregulation in the analyzed organs, and although liver does not show increased Ptch1 expression, Ptch1 is induced in lung, spleen and brain. Thus, these organs not only generate Shh in response to hypoxia, but also respond to it by activation of the Hh pathway, leading to Ptch1 expression.
Normobaric hypoxia induces a Shh response in an in vitro model for hypoxic cardiac muscle
The abovementioned data do not explain the exact mechanism by which Shh expression is triggered by hypoxia, and to be better able to assess the mechanism behind this Hh response, we employed an in vitro model system to study Hh pathway activation. Rat cardiomyoblast cells (H9c2 (Kimes and Brandt, 1976) ) were subjected to low oxygen levels (1% normobaric) in an airtight thermostated chamber. , mice were sacrificed (n = 2 mice per time point). Animals maintained under normal oxygen conditions were used as normoxic controls. Organs (brain, liver, lung and spleen) were homogenized in lysis buffer and subjected to Western blot analysis using antibodies against Shh (Coomassie stain served as loading control). Signals were quantified, corrected for Coomassie signal and expressed as the percentage of the signal for mice from normoxic conditions (expressed as t = 0; mean+/-SEM).
(C) Quantification of Western blots as for B, but using antibodies against Ptch1.
After hypoxic stimulation, cells were lysed and immunoblotted. As expected, HIF-1α levels rose quickly after exposure to low oxygen levels ( Fig  2A, upper panel) . Within 1 hour, maximal levels were reached. Together with the accumulation of HIF-1α, an increase in mature Shh protein levels was observed (lower panel), peaking about 1 hour later than HIF-1α. In response to the expressed Shh, Ptch1 levels were also elevated. The lower band on the Ptch1 blot was not identified, but probably represents either a breakdown product of Ptch1 following Shh stimulation or a splice variant (Shimokawa et al., 2007) . After 6h of hypoxia, levels of the analyzed proteins had normalized. Densitometric quantification and statistical justification of Western blots as shown in Fig 2A is shown in Fig 2B. The kinetics of these results predict that hypoxia leads to rapid HIF-1α accumulation, which initiates Shh transcription and translation, leading to pathway activation, and as a negative feedback, Ptch1 expression.
To formally confirm that Hh pathway transcription factors (Gli proteins (Sasaki et al., 1997) ) are activated in the cardiomyoblasts by hypoxia, we transfected these cells with a reporter construct that is sensitive to activation of the Gli1 and -2. In analogy to the Ptch1 expression following hypoxia (indicative of pathway activation), induction of reporter activity after 2 hours of 1% O 2 was seen, thus confirming activation of the Gli proteins in response to hypoxia. Stimulation of reporter-transfected cells with 300 ng/ml recombinant Shh activated the Hh pathway to a similar magnitude as observed with hypoxia. This confirms the Hh-responsiveness of the H9c2 cells, as well as hints to the amount of Shh produced by the cardiomyoblasts, which should be roughly similar to the 300 ng/ml added exogenously.
FIGURE 2. NORMOBARIC HYPOXIA INDUCES A HEDGEHOG PATHWAY RESPONSE IN CARDIOMYOBLASTS
(A) H9c2 rat cardiomyoblasts were grown to full confluence and exposed to 1% O 2 for the times indicated. After hypoxia, cells were rapidly lysed and analyzed by Western blot using antibodies against HIF-1α, Shh, Ptch1 and β-actin (loading control). Please note different time scale for the HIF-1a blot. (B) Western blots as described for A were quantified as for Fig. 1C . using β-actin as loading control. Mean+/-SEM is shown of three independent experiments. (C) Cardiomyoblasts were transfected with a Gli-reporter construct and exposed to 1% O 2 or stimulated with 300 ng/ml Shh for times indicated. After lysis, luciferase activity was assayed and values were expressed as percentage increase relative to t=0. Mean+/-SEM is shown, n≥3.
Normobaric hypoxia induces a Shh response in fibroblasts
To verify that the effects of MK-886 on the induction of To be able to use embryonic fibroblasts from mice knock-out for relevant genes, we first needed to confirm that the Hh pathway is also activated in fibroblasts in response to hypoxia as observed in the myocardioblasts. The Hh pathway activity in response to hypoxia was assessed in a murine fibroblast cell line routinely used for Hh research (NIH-3T3 fibroblasts) stably transfected with the abovementioned Gli-reporter construct (Shh-LIGHT II (Taipale et al., 2000) ). As shown in Fig 3A, the fibroblasts respond to hypoxia by activating the Hh pathway, suggesting that these fibroblasts are a good model for studying hypoxia-induced Hh responses.
To confirm that Shh expression and secretion is mediating the Hh pathway response to hypoxia, Hh pathway activation to hypoxia was determined in the abovementioned Shh-LIGHT II cells pretreated with 1 μg/ml 5E1 Shhblocking antibody (Ericson et al., 1996) . The 5E1 antibody binds to the epitope on Shh that is also required for binding to its receptor Ptch1, and thereby 5E1 inactivates Shh released into the medium. This treatment was successful in abrogating the pathway response to hypoxia as shown in Fig 3B, suggesting that indeed Shh secretion in response to hypoxia is responsible for increasing Hh pathway activity. Shh levels were already increased after 60 min of hypoxia (Fig  2) , which might seem a short time for de novo protein expression. To formally confirm that transcription and translation are indeed required for Shh levels to rise, we used transcriptionand translation blockers on fibroblasts subjected to hypoxia and determined Shh levels as for Fig 2A-B . Pretreatment with 5 μg/ml actinomycin D (transcription inhibitor) or 1 μg/ml cycloheximide (translation inhibitor) completely abrogated the expression of Shh in response to hypoxia (Fig  3C) , confirming that de novo transcription and translation are responsible for the observed Shh production and subsequent pathway activation.
HIF-1α mediates the Shh response to hypoxia
Classically, cells sense hypoxic conditions through HIF-1α. HIF-1α accumulates in response to hypoxia and mediates the transcription of various target genes. To test if the observed HIF-1α accumulation is required for the Shh response to hypoxia, we pretreated Shh-LIGHT II cells with a panel of inhibitors known to inhibit HIF-1α accumulation, including 2-ME2 (Powis and Kirkpatrick, 2004) . 2-ME2 is a pharmacological inhibitor that depolymerizes microtubules and thereby blocks HIF-1α nuclear accumulation in response to hypoxia (Mabjeesh et al., 2003) and thus paralyzes the protein in acting as a transcriptional activator. As can be seen in Fig 4A , pretreatment of cells with 30 μM 2-ME2 was able to abrogate Hh pathway activation following hypoxia. Although this inhibitor is widely used as an inhibitor of HIF-1α, it is also known to interfere with other processes dependent on microtubule dynamics (Mabjeesh et al., 2003) , and we therefore used several other inhibitors known to affect HIF-1α activity in different ways. By using rapamycin (mTOR inhibitor (Zhong et al., 2000) ) and wortmannin (PI-3K inhibitor (Sandau et al., 2000) ), the transcription and translation of HIF-1α was inhibited (Powis and Kirkpatrick, 2004) . Similar to 2-ME2, these inhibitors are not strictly specific for HIF-1α but as these inhibitors, which do not share off-target effects, all abrogate Hh pathway activity at least some specificity for HIF-1α inhibition could be argued. or stimulated with 300 ng/ml recombinant Shh for times indicated. After lysis, luciferase activity was assayed and expressed as described for Fig 2C. Mean+/-SEM is shown, n=6. (B) Shh LIGHT II cells were preincubated for 20 min with 1 μg/ml 5E1 Shh-blocking antibody and exposed to 1% O 2 for 120 min. After lysis, luciferase activity was assayed and expressed as described for Fig 2C. (C) C3H/10T1/2 cells were pretretated for 20 min with actinomycin and cycloheximide at the concentrations indicated and subsequently subjected to 1% O 2 for 120 min. Cells were lysed and analyzed by Western blot using antibodies against Shh, and β-actin and densitometry was performed as for Fig 1B. (Stiehl et al., 2006) ) to hypoxia and determined Shh protein levels. As shown in Fig 4B , Shh levels were raised by low oxygen conditions in fibroblasts from wild type mice, whereas fibroblasts from HIF-1α knock-out mice were incapable of this response. This confirms that indeed, HIF-1α is required for Shh expression in response to hypoxia.
To assess the requirement for HIF-1α in the activation of the Hh pathway transcription factors by hypoxia, we employed siRNA knockdown of HIF-1α in Shh-LIGHT II cells, as well as reporter transfection of the abovementioned fibroblasts from mice knock-out or wild type for HIF-1α (Fig 4C) . Following ablation of HIF-1α by either method, no activation of the Hh pathway transcription factors could be observed, providing definitive evidence that HIF-1α is essential in mediating the Hh response to hypoxia. Figure 4D shows the reduction in HIF-1α protein level after siRNA transfection and subsequent hypoxia (the hypoxia was necessary to induce HIF-1α to measurable levels). Although the reduction in protein is definitely not complete, it is enough to abrogate the Hh response as shown by the data from Figure  4C . Concluding, the presented data show that cells are able to respond to an oxygen-poor environment by expression of Shh, mediated by HIF-1α.
Discussion
In this study, we set out to investigate whether one of the most prominent features of ischemia, i.e. hypoxia, was able to induce a Hh response both in vivo and in vitro. By exposing mice to low oxygen levels, we were able to show a widespread Hh response. Mechanistic studies in cardiomyoblasts and fibroblasts mimicked the effects observed in vivo, and showed that HIF-1α accumulation was required for the Hh response. These findings show that of the plethora of disturbed processes in ischemic tissue, hypoxia per se is able to induce a Hh response. Based on these data we propose the following model for Hh action in hypoxic tissue; an occluded vessel restricts blood flow to tissue, which subsequently becomes hypoxic. HIF-1α levels rise due to these hypoxic conditions leading to for 120 min. After lysis, luciferase activity was assayed and expressed as described for Fig 2C. (B) Hif1α +/+ Hras TAg or Hif1α -/-Hras TAg mouse embryonic fibroblasts were subjected to hypoxia for the times indicated, lysed and analyzed by Western blot using antibodies against Shh, and β-actin. (C) Shh LIGHT II cells were transfected with siRNA for HIF-1α or scrambled control and subjected to 120 min 1% O 2 , lysed and analyzed as described for Fig. 2C . Hif1α +/+ Hras TAg or Hif1α -/-Hras TAg mouse embryonic fibroblasts were transfected with Gli-reporter construct and subjected to 1% O 2 for 120 min. (D) fibroblasts were transfected with siRNA for HIF-1α or scrambled control for 24h, subjected to hypoxia for 2h, lysed and analyzed by Western blot using antibodies against HIF-1α, and β-actin** = p<0.01, Student's t-test.
de novo expression of Shh subsequently activating its pathway. It is tempting to speculate that as a consequence, transcriptional targets of Shh, like among others, vascular endothelial growth factor (VEGF) and the angiopoietins (Ang 1/2) are expressed, thereby leading to tissue vascularization and the reduction of tissue damage. However this latter notion needs to be confirmed in future experiments.
The proposed model would not only explain the upregulation of Shh as seen in ischemia models, but might also have intriguing implications for other conditions in which individuals are exposed to low oxygen levels, for instance flight or high altitude (sometimes leading to significant arterial hypoxia without symptoms), or situations such as COPD or asphyxia. An interesting preliminary observation in this regard comes from pilot experiments involving non-smoking volunteers. After challenging the volunteers with tobacco smoke, isolated neutrophils were found to have almost 2-fold higher levels of Ptch1 mRNA within 6 hour after first inhalation. It should be noted however that tobacco smoke does not only induce hypoxia, but affects many other physiological processes, making the data from these experiments inconclusive and further studies into this phenomenon are planned.
Some issues should be kept in mind when interpreting our data. The murine experiments depicted in Fig. 1 clearly indicate that systemic hypoxia leads to Shh expression but they also indicate that some discrepancy between Shh levels and the subsequent Hh pathway activity in a given organ exists. Especially the fact that Shh protein levels are easily detected in liver of mice subjected to hypoxia whereas no Hh pathway activity is detected in these livers is puzzling. One could however argue that the amount of Shh produced is not sufficient to block all Ptch1 receptors. Alternatively, the majority of hepatocytes might not have a functional Hh pathway and consequently Shh expression does not lead to pathway activation (see also the data on HepG2 cells in (Huang et al., 2006) ). Whatever the explanation however, it does not conflict with the main message of our manuscript.
In summary, we sought to determine whether hypoxia triggers the Hh pathway. Our data confirm that hypoxia indeed leads to HIF-1α dependent Shh expression and consequent Hh pathway activity. We suggest that this activation by hypoxia per se might explain the observed Shh expression in the ischemia models as described by others.
Materials and Methods
Animals and exposure of mice to hypoxia C57BL/6 wild type mice were purchased from Charles River (Zeist, The Netherlands). All mice were housed and fed according to routine procedures and were used at 8-10 weeks of age. The experiments were approved by the Institutional Animal Care and Use Committee of the Academic Medical Center, Amsterdam, The Netherlands. Mice were exposed to normobaric hypoxia using a custom-made hypoxia-chamber containing an oxygen sensor (Marin Assist, Hazerswoude, The Netherlands). Mice were placed in the hypoxia chamber and the oxygen level was lowered to 8% within one hour. After 16h of 8% O 2 , animals were sacrificed by bleeding from the vena cava inferior after being anesthetized (by intraperitoneal injection of FFM ((1:1:2 hypnorm (Janssen Pharmaceutica, Beerse, Belgium), dormicum (Roche, Mijdrecht, The Netherlands), sterile water for injection (Braun Melsungen AG, Melsungen, Germany); 0.1 ml per 10 grams body weight). Immediately before the mice were sacrificed, body temperature (intrarectal) and weight were measured, pO 2 , pCO 2 , HCO 3-, hemoglobin and hematocrit levels of mice exposed to 8% O 2 were analyzed. Blood was sampled by heart puncture via a lateral approach and analyzed using an ABL 505 blood gas analyzer and an OSM3 oxymeter (Radiometer, Copenhagen, Denmark).
Materials
The 5E1 Shh-blocking antibody was from the Developmental Hybridoma Bank (Iowa City, IA). Rapamycin, wortmannin and 2-methoxyestradiol (2-ME2) were purchased from Sigma (St. Louis, MO).
Cell culture and exposure of cells to hypoxia C3H/10T1/2 mouse mesenchymal fibroblasts (from American Type Culture Collection CCL-226, Manassas, VA), were grown in DMEM (Cambrex, East Rutherford, NJ) containing 10% fetal calf serum (FCS (Cambrex, East Rutherford, NJ)). The Shh-LIGHT II mouse fibroblast cell line (ATCC number CRL-2795) was maintained in DMEM with 10% FCS, 0.4 mg/ml G418 and 0.16 mg/ml Zeocin. Hif1α +/+ Hras TAg or Hif1α -/-Hras TAg mouse embryonic fibroblasts were kindly provided by Dr Camenisch and grown as the C3H/10T1/2 cells. All media were supplemented with L-glutamine. Cells were exposed to normobaric hypoxia using a custom-made hypoxia-chamber and premixed gas containing 1% O 2 , 5% CO 2 and 94% N 2 in a normal cell culture incubator. After incubation, cells were quickly lysed for Western blot analysis or luciferase assays.
Western Blotting
Cells were lysed in Laemmli buffer and brought onto SDS-PAGE gels. After electrophoresis, protein was transferred onto Immobilon-PVDF membranes (Millipore, Billerica, MA). Membranes were blocked in 3% Protifar (Nutricia) in Tris buffered saline/0.1% Tween-20 (TBST) for 1h. Goat polyclonal α-Ptch1 G-19 (Santa Cruz Biotechnology, Santa Cruz, CA), 5E1 α-Shh (Developmental Studies Hybridoma Bank, Iowa City, IA), α-Shh (Cell Signaling, Danvers, MA) or α-HIF-1α (Novus Biologicals, Littleton, CO) antibodies were diluted 1:500 (1:1000 for β-actin) in 1% BSA (SigmaAldrich) in TBST and membranes were incubated overnight. After 1h incubation in 1:1000 α-goat or α-rabbit HRP-conjugated secondary antibody (DakoCytomation, Glostrup, Denmark), blots were imaged using LumiLight Plus ECL (Roche, Basel, Switzerland) on a LAS 3000 Imager (Fuji Photo Film, Tokyo, Japan). Densitometry was performed using the histogram function in Adobe Photoshop 7.0 (mean intensity determined in selection of constant area (Adobe Systems, San Jose, CA)).
Luciferase assays
After treatment, cells were lysed with passive lysis buffer as provided by Promega and luciferase activity was assayed according to the Promega Dual-Glo Luciferase Assay System protocol on a Lumat Berthold LB 9501 Luminometer. Firefly luciferase values were corrected for co-transfected CMV driven Renilla luciferase standard to correct for transfection efficiency or dilution effects. Values were expressed as percent difference to control conditions.
Transfections
Transfections of pre-designed siRNA (control and Silencer HIF-1α siRNA; ID#158954), obtained from Ambion Inc (Austin, TX) were performed using RNAiFect (Qiagen, Hilden, Germany) according to the manufacturer's protocol and as described previously (Bijlsma et al., 2006) . Cells were incubated with transfection complexes for 16 h, after which fresh medium was added for another 6 h preceding further experimentation.
Statistics
Statistical analyses were conducted using GraphPad Prism version 4.00, GraphPad software (San Diego, CA, USA). Data are expressed as means ± SEM. Comparisons between two conditions were analyzed using two-tailed unpaired t-tests. *, p<0.05; **, p<0.01; ***, p<0.005.
